- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 8M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $23K |
| Capex | Q1 2026 · Mar 31, 2025 | $5K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $121K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $227K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$4.22M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$4.06M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$4.09M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$3.93M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.58M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.05M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.58M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.81M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.41M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.13M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.82M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.12M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $892K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $156K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $187K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$220K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$256K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$190K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$215K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $954K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $992K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.32M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.13M |